20195 ⎘
Medicinal preparations containing organic active ingredients Nitro compounds
Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
#302Microdose therapy
#303Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
#304Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
#305Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
#306Mobilization of hematopoietic cells
#307Nitrate esters and their use for mitigating cellular damage
#308Therapeutic use of aerosolized nitrosylating agent in cystic fibrosis
#309Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
#310Transdermal and topical administration of drugs using basic permeation enhancers
#311Anti-glycation agents for preventing age- diabetes- and smoking-related complications
#312Stabilized compositions containing an oxygen-labile active agent and a fungal extract
#313Treatment of nail infections with no
#314Composition for treating wounds, dermatitis, inflammation, and irritation
#315Dihydropyrimidinone derivatives
#3162, 4-dinitroanilino-benzoic acid: novel insulinotropic agent for the treatment of diabetes
#317Capsule for sublingual and gastro-intestinal delivery of a liquid medication in a single volume limited dose
#318Method of stabilizing human eye tissue